About Micro medical solutions
Micro Medical Solutions: Revolutionizing the Treatment of CLI Amputations
Micro Medical Solutions is a company that is dedicated to transforming the way we treat critical limb ischemia (CLI) amputations. CLI is a severe form of peripheral artery disease (PAD) that affects millions of people worldwide. It occurs when there is a blockage in the arteries that supply blood to the legs and feet, leading to tissue damage, ulcers, and eventually amputation.
The statistics surrounding CLI are alarming. According to recent studies, approximately 160,000 amputations are performed each year in the United States alone due to complications from PAD. This number is expected to rise as our population ages and more people develop diabetes and other risk factors for PAD.
However, Micro Medical Solutions believes that these numbers can be reduced significantly with their innovative technology. The company has developed a minimally invasive device called MicroStent™ that can be used to treat patients with CLI before they reach the point of requiring an amputation.
The MicroStent™ device works by opening up blocked arteries in the leg using a small metal scaffold. Unlike traditional stents which are designed for larger vessels, MicroStent™ has been specifically engineered for use in smaller vessels found in patients with CLI.
One of the key benefits of this technology is its ability to preserve blood flow through collateral vessels – tiny pathways created by nature over time – which help keep tissues alive even when major arteries become blocked or damaged.
Another advantage of using MicroStent™ over traditional treatments such as balloon angioplasty or bypass surgery is its minimally invasive nature. Patients who undergo these procedures often require lengthy hospital stays and have higher rates of complications such as infection or bleeding.
With MicroStent™ treatment, patients can typically return home on the same day as their procedure and resume normal activities within days rather than weeks or months.
Micro Medical Solutions has already received FDA approval for their device and has begun clinical trials across multiple sites throughout Europe and North America. The results so far have been promising with high success rates reported among treated patients without any significant adverse events reported during follow-up periods ranging from six months up until two years post-treatment.
In addition to developing innovative medical devices like MicroStent™, Micro Medical Solutions also places great emphasis on education about PAD prevention strategies such as smoking cessation programs or regular exercise routines tailored specifically towards those at risk for developing PAD symptoms like leg pain while walking (claudication).
Overall, it's clear that companies like Micro Medical Solutions are making significant strides towards improving patient outcomes while reducing healthcare costs associated with treating conditions like critical limb ischemia (CLI). With continued research into new technologies aimed at preventing unnecessary amputations caused by this debilitating disease process – we may soon see an end to this devastating condition once-and-for-all!